TABLE 2.
Apnea |
Bradycardia |
|||
---|---|---|---|---|
No Future Events, n (%) | Future Events, n (%) | No Future Events, n (%) | Future Events, n (%) | |
Male gendera | 605 (51.1) | 118 (53.9) | 566 (51.3) | 157 (52.5) |
Gestational age | ||||
<26 wk | 61 (65.6) | 32 (34.4) | 54 (58.1) | 39 (41.9) |
27–28 wk | 113 (73.4) | 41 (26.6) | 102 (66.2) | 52 (33.8) |
29–30 wk | 196 (77.2) | 58 (22.8) | 172 (67.7) | 82 (32.3) |
31–32 wk | 316 (86.8) | 48 (13.2) | 295 (81.0) | 69 (19.0) |
33–34 wk | 498 (92.6) | 40 (7.4) | 481 (89.4) | 57 (10.6) |
Discharged on oxygen | 54 (4.6) | 25 (11.4) | 51 (4.6) | 28 (9.4) |
Bronchopulmonary dysplasia | 94 (7.9) | 47 (21.5) | 84 (7.6) | 57 (19.1) |
Necrotizing enterocolitisa | 13 (1.1) | 2 (0.9) | 12 (1.1) | 3 (1.0) |
Intraventricular hemorrhage stages III–IV | 11 (0.9) | 7 (3.2) | 10 (0.9) | 8 (2.7) |
Infants with future events not statistically significant from infants without future events for both apnea and bradycardia.